المؤلفون: Mosele MF; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich., Stenzinger A; Institute of Pathology, University Hospital Heidelberg and Center for Personalized Medicine (ZPM), Heidelberg, Germany., Barlesi F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre., Bayle A; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre; Drug Development Department (DITEP), Gustave Roussy, Villejuif; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif., Bièche I; Department of Genetics, Institut Curie, INSERM U1016, Université Paris Cité, Paris, France., Bonastre J; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid., Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona; University of Vic-Central University of Catalonia, Vic, Spain; Oncoclínicas, São Paulo, Brazil., Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif., Miller R; Department of Medical Oncology, University College London, London; Department of Medical Oncology, St Bartholomew's Hospital, London, UK., Normanno N; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Reis-Filho J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Robson M; Breast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Rouleau E; Tumor Genetics Service, Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France., Scarpa A; Section of Pathology, Department of Diagnostics and Public Health, University of Verona-School of Medicine, Verona, Italy., Serrano C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona., André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre. Electronic address: education@esmo.org.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 588-606. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: High-Throughput Nucleotide Sequencing*/methods , High-Throughput Nucleotide Sequencing*/standards , Precision Medicine*/methods , Precision Medicine*/standards , Neoplasms*/genetics , Neoplasms*/pathology , Neoplasms*/therapy, Humans ; Medical Oncology/methods ; Medical Oncology/standards ; Europe

المؤلفون: Tarantino P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan., Viale G; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy., Press MF; Department of Pathology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, USA., Hu X; Department of Medical Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China., Penault-Llorca F; Centre de Lutte Contre le Cancer Centre Jean PERRIN, Clermont-Ferrand, France., Bardia A; Harvard Medical School, Boston, USA; Department of Medical Oncology, Massachusetts General Hospital, Boston, USA., Batistatou A; Department of Pathology, Faculty of Medicine, University of Ioannina, Ioannina, Greece., Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, USA., Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA., Cortes J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Denkert C; Philipps-University Marburg and University Hospital Marburg (UKGM), Marburg, Germany., Diéras V; Department of Medical Oncology, Centre Eugène Marquis, Rennes., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, INSERM U1194, Montpellier, France., Koutras AK; Division of Oncology, Department of Medicine, University Hospital of Patras, Greece., Lebeau A; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg., Loibl S; German Breast Group/GBG Forschungs GmbH, Neu-Isenburg; Goethe University Frankfurt, Frankfurt, Germany., Modi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Mosele MF; Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France., Provenzano E; Department of Histopathology, Cambridge University NHS Foundation Trust and NIH Cambridge Biomedical Research Centre, Cambridge, UK., Pruneri G; Department of Oncology and Hemato-Oncology, University of Milan, Milan; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Rojo F; Department of Pathology, IIS-Fundacion Jimenez Diaz University Hospital-CIBERONC, Madrid, Spain., Salgado R; Department of Pathology, ZAS, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia., Schmid P; Barts Cancer Institute, Queen Mary University London, London, UK., Schnitt SJ; Harvard Medical School, Boston, USA; Department of Pathology, Brigham and Women's Hospital and Breast Oncology Program, Dana-Farber Cancer Institute, Boston, USA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, USA., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan; European Institute of Oncology, IRCCS, Milan, Italy., Vincent-Salomon A; Department of Pathology, Diagnostic and Theranostic Medicine Division, Institut Curie, PSL University, Paris, France., Wolff AC; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA., Pentheroudakis G; European Society for Medical Oncology, Lugano, Switzerland., André F; INSERM U981 - Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan; European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Aug; Vol. 34 (8), pp. 645-659. Date of Electronic Publication: 2023 Jun 01.

نوع المنشور: Review; Practice Guideline

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnosis , Breast Neoplasms*/drug therapy, Humans ; Female ; Consensus ; Medical Oncology

المؤلفون: Aldea M; Department of Medicine, Gustave Roussy, Villejuif, France.; University of Paris Saclay, Paris, France., Tagliamento M; Department of Medicine, Gustave Roussy, Villejuif, France.; Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy., Bayle A; University of Paris Saclay, Paris, France.; Drug Development Department, Gustave Roussy, Villejuif, France., Vasseur D; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Vergé V; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Marinello A; Department of Medicine, Gustave Roussy, Villejuif, France., Danlos FX; University of Paris Saclay, Paris, France.; Drug Development Department, Gustave Roussy, Villejuif, France., Blanc-Durand F; Department of Medicine, Gustave Roussy, Villejuif, France., Bernard E; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France., Cerbone L; Department of Medicine, Gustave Roussy, Villejuif, France., Mosele MF; Department of Medicine, Gustave Roussy, Villejuif, France., Renneville A; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Hadoux J; Department of Medicine, Gustave Roussy, Villejuif, France., Loriot Y; Department of Medicine, Gustave Roussy, Villejuif, France.; Drug Development Department, Gustave Roussy, Villejuif, France., Sakkal M; Department of Medicine, Gustave Roussy, Villejuif, France.; Drug Development Department, Gustave Roussy, Villejuif, France., Vozy A; Department of Medicine, Gustave Roussy, Villejuif, France., Sarkozy C; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France., Smolenschi C; Department of Medicine, Gustave Roussy, Villejuif, France.; Drug Development Department, Gustave Roussy, Villejuif, France., Nicotra C; Drug Development Department, Gustave Roussy, Villejuif, France., Martin-Romano P; Drug Development Department, Gustave Roussy, Villejuif, France., Boccon-Gibod C; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France., Habza W; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France., Lazarovici J; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France., Ponce S; Drug Development Department, Gustave Roussy, Villejuif, France., Hollebecque A; Drug Development Department, Gustave Roussy, Villejuif, France., Marzac C; Drug Development Department, Gustave Roussy, Villejuif, France.; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France., Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Barlesi F; Department of Medicine, Gustave Roussy, Villejuif, France.; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France., André F; Department of Medicine, Gustave Roussy, Villejuif, France.; University of Paris Saclay, Paris, France., Besse B; Department of Medicine, Gustave Roussy, Villejuif, France.; University of Paris Saclay, Paris, France., Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Italiano A; Department of Medicine, Gustave Roussy, Villejuif, France.; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France., Micol JB; University of Paris Saclay, Paris, France.; Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France.

المصدر: JCO precision oncology [JCO Precis Oncol] 2023 Mar; Vol. 7, pp. e2200583.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA*/genetics , Hematologic Neoplasms*/genetics , Neoplasms, Unknown Primary* , Hematology*, Adult ; Humans ; Splicing Factor U2AF ; Transcription Factors ; Liquid Biopsy